Advisory Board & Key Personnel

Dr Mohi Rezvani

The founder, Chief Scientific Officer and member of SBS Board of Directors, Mohi Rezvani is the former director of the University of Oxford’s Research Institute at Churchill Hospital, Oxford. Mohi started his career in biology by studying the mechanisms of development and the treatment of radiation-induced normal tissue injuries in order to ameliorate radiation lesions caused by accidental exposure to ionising radiation or as side effects of radiotherapy of cancer. He investigated the potential and efficacy of a number of pharmaceuticals, plant extracts and stem cells as therapeutics. His main interest is development of stem cell based treatments particularly by utilisation of the paracrine effect of stem cells and sub-cellular substances such as extracellular vesicles.

Mohi is a fellow of the Royal Society of Medicine (RSM) and a fellow of the Royal Society of Biology (RSB). He is the former Chairman of the UK Radiation Research Society and the former President of European Radiation Research Society.

Sara Enz

Ms Sara Enz, cell manufacturing technician, has vast experience in cell biology and production of stem cells. Sara is currently in charge of laboratory management and stem cell production. Her valuable background in Molecular Biology, Biochemistry and Developmental Biology has brought a different perspective and enhancements to the team’s strength and skills.

Professor Dr. Ralf Peter

During his distinguished career as a professor, lecturer, scientist and practising, consultant physician. Professor Peter has established a reputation as an internationally renowned expert in the fields of Dermatology, Vascular Surgery and Venereology. Ralf is currently Medical Director, CEO, and majority shareholder of the Centre for Vascular Surgery and Dermatology, Ulm-Blaustein, Germany and Editor of the Journal of Venereology and Professor of Dermatology at the University of Ulm. Previously Ralf was Senior Scientist, Institute of Radiobiology, Armed Forces Medical Academy, Munich, Germany, Resident in Dermatology and Consultant in Dermatologic Radiotherapy and Oncology at the Dept. of Dermatology, Ludwig-Maximilian-University of Munich, Professor and Chairman of the Dept. of Dermatology and Venereology of the University of Ulm, and Chief of the Dept. of Dermatology at the Armed Forces Hospital in Ulm, Germany and President of the German Society of Wound Healing. Ralf graduated in Studies of Medicine at the Justus-Liebig-University, Giessen, Germany and undertook a Clinical Clerkship at the Massachusetts General Hospital, Boston, Harvard Medical School. Peter has published more than 350 publications, among these more than 180 in Medline-listed Journals and has authored four books.

Professor Munira Kadhim

Professor Kadhim is an internationally established expert in the field of radiation biology who has published extensively in this field. Munira is currently leading the research on cellular/tissue effects of damaging agents at Oxford Brookes University, UK. Prior to moving to Oxford Brookes University, Munira held positions at Swansea University, UK; Weatherall Institute of Molecular Medicine, University of Oxford and Medical Research Council, UK, where she led the ‘Genomic Instability Group. Munira is a pioneer on Non Targeted Effects and Bystander Effects of radiation and her team was the first to publish on the radiation induced extracellular vesicles (EV). Since then the EV-specific radiation biology has undergone a massive expansion with other groups working on all aspects of EV biology subsequent to Non Targeted Effects of radiation. Munira is a member of several national and International committees and scientific societies including: Committee on Medical Aspects of Radiation in the Environment ‘COMARE’, ‘COMARE CT and DXA Sub-committee ( Department of Health UK )’, ‘UK Association for Radiation Research’, The Clinical and Translational Radiotherapy Research Working Group (CTRad), The European Radiation Research Society (ERR); Radiation Research Society, USA’ and ‘Mutagenesis Society’.

Dr Med. Roger Gmür

Specialist for Plastic and Aesthetic Surgery FMH for plastic, reconstructive and aesthetic surgery. Diplomate of the European Board of Plastic, Reconstructive and Aesthetic Surgery. Dr. med. Roger Gmür has his practice in Klinik Tiefenbrunnen. After board certification and further education at university and different clinical settings, he founded Klinik Tiefenbrunnen together with his partner Dr. med Lucas Leu. Dr. Gmür is a specialist in treatments and operations to improve the body contours. More specifically, he has established himself a name in the field of liposuction and breast augmentation with autologous fat transplantation. He leads workshops in lipofilling techniques for surgeons from home and abroad in the Klinik Tiefenbrunnen.

Professor Frank Van Gansbeke

  • Frank acquired more than 30 years of global Senior Executive experience within the Corporate Finance and Capital Markets fields at Fortis and BNPP.
  • Frank has an M.B.A. from Catholic University of Leuven (Belgium), is a CFA charter holder and obtained certifications at MIT in FinTech and at Oxford Said Business School in Impact Investing & Private Equity.
  • At Middlebury College (US), Frank is a Professor of the Practice, where he teaches “Capital Markets”, “Introduction to Corporate Finance” and mentors at Middcore, its West Coast entrepreneurial immersion program.
  • Frank is founder and managing partner of Goose Creek Ventures, LLC, advising and angel investing in global, early stage companies evolving on the nexus of FinTech, Medtech and sustainable development.
  • Within this capacity, Frank is a board member of several companies with a global footprint.

Dr Dave Carter

Prof Dave Carter is a Professor in the Faculty of Health and Life Sciences at Oxford Brookes University (OBU). Dave is a cancer biologist and renowned scientist in the field of extracellular vesicles and non-coding RNAs. He is currently conducting research programs on cargo and delivery of extracellular vesicles and the role of miRNAs and extracellular vesicles in regulating drug resistance in cancer response and intercellular stress. Before joining OBU, Dave spent a year in Cambridge working on the human genome project at the Sanger Institute. This was followed by his PhD, in Cambridge, where he developed a novel assay, ‘RNA-tagging and recovery of associated proteins’, to demonstrate a physical interaction between a locus control region and the β-globin gene. Later he investigated the structure of transcription factors at at Oxford University, before establishing his own lab in 2007. Dave is the current president of the UK Society for Extracellular Vesicle.

Mr. Markus Hunziker

After completing his PhD in chemistry at Swiss Federal Institute of Technology in Zürich, Markus Hunziker started his career in the pharmaceutical industry. During his career, he gained extensive experience in GMP and GDP Quality Assurance. Dr Hunziker served as Head of QA and Qualified Person (QP) in pharmaceutical industry. As GMP and GDP QA Specialist, Markus Hunziker has more than 20 years of professional experience in the field of quality management at manufacturing and wholesale in pharmaceutical industry. Markus Hunziker is a certified GMP and ISO auditor as well. Currently he is acting as QP for several different companies.
Scroll to Top